VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

BACKGROUND: Combination of fluoropyrimidines and a platinum derivative are currently standards for systemic chemotherapy in advanced adenocarcinoma of the stomach and gastroesophageal junction (GEJ). Nevertheless, individual likelihood for response to these therapeutic regimes remains uncertain. Eve...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Thomaidis, Thomas, Maderer, Annett, Al-Batran, Salah-Eddin, Kany, Janis, Pauligk, Claudia, Steinmetz, Kristina, Schad, Arno, Hofheinz, Ralf, Schmalenberg, Harald, Homann, Nils, Galle, Peter Robert, Moehler, Markus
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2014
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4094395/
https://ncbi.nlm.nih.gov/pubmed/24981311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-476
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы